Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otsuka Holdings Co. Ltd.

www.otsuka.com

Latest From Otsuka Holdings Co. Ltd.

Vitafusion Absorption Claim Review May Touch Supplement Industry Nerve About Disclosures

Council of Better Business Bureaus division, reviewing Pharmavite challenge, found Church & Dwight doesn't support or sufficiently qualify “clinically proven absorption” claims for vitafusion vitamin C and D3 products in a decision that swung on a corollary to an oft-cited standard for consumer health product advertising, that results of tests on separate ingredients are not relevant to claims for products.

Dietary Supplements Ad Complaints

Deal Watch: Vir Partnering With Alnylam, WuXi On Coronavirus Treatments

US biotech expands 2017 collaboration with Alnylam and inks collaboration with WuXi. Plus deals involving AbbVie, Allergan, Amazon, Thermo Fisher, Qiagen, Boehringer Ingelheim, Trutino, Taiho, Arcus, Eisai, Fuji Yakuhin, Hikma, Glenmark, Hanmi, GC, Bayer, GW.

Deals M & A

Humana Medicare Advantage Plans Targeting Hemlibra, Herceptin Hylecta With Step Therapy

Fail first requirements for 2020 also target drugs for myelodysplastic syndrome and chronic obstructive pulmonary disease, building on the step therapy program launched by Humana in 2019.

Reimbursement Pricing Strategies

Asia Deal Watch: BeiGene Leaps Into New Year By Licensing DKK1 Antibody Candidate

BeiGene’s license agreement with Leap Therapeutics covers Asia, except for Japan, along with Australia and New Zealand. Apollomics obtains rights in China and beyond to GlycoMimetics’ e-selectin antagonists.

Deals Business Strategies
See All

Company Information

UsernamePublicRestriction

Register